In Vivo PBMC-Humanized Mouse Model to Assess Individual Variability in Efficacy and Toxicity of Autologous and Allogeneic Chimeric Antigen Receptor T-Cell Immunotherapy
Won Lee(Gachon University), Jiwon Yang(Burke Medical Research Institute), Mingshan Cheng(Jackson Laboratory), James Keck(Jackson Laboratory), Destanie Rose(Jackson Laboratory), Rebecca Gardner(Seattle Children's Hospital), Heather Gustafson(Seattle Children's Hospital)
Cited by 1
Related Papers
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
CD19 CAR T cell product and disease attributes predict leukemia remission durability
|Journal of Clinical Investigation|2019|355
Humanized mice in studying efficacy and mechanisms of PD‐1‐targeted cancer immunotherapy
|The FASEB Journal|2017|352